Patent · US Active

Compounds for the treatment of neurodegenerative diseases

US9085549B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 15, 2014
Grant dateJul 21, 2015
Priority date
Expiry dateSep 15, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D409/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Compounds and their pharmaceutically acceptable salts for treatment of synucleinopathies, such as Parkinson's disease and tauopathies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.